Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 51 - 100 out of 3,567

Document Document Title
WO/2012/177357
The present application relates to perfume raw materials, perfume delivery systems and consumer products comprising such perfume raw materials and/or such perfume delivery systems, as well as processes for making and using such perfume r...  
WO/2012/175650
The present invention relates to a method for the hydrothermolysis of a mono- and/or oligosaccharide-comprising composition which in addition comprises at least one monoalkyl and/or dialkyl ether of a polyalkylene glycol, and also relate...  
WO/2012/169559
In order to provide a novel azole derivative, the azole derivative of the present invention is an azole derivative represented by general formula (V'). (In the formula, each of R6 and R7 independently represents a hydrogen atom, an alkyl...  
WO/2012/158107
Linear or cyclic carbonates as potential monomers for isocyanate-free polyurethanes and polycarbonates were prepared from polyols and dialkylcarbonatesor diphenyl carbonates. This invention was developed to produce linear or cyclic carbo...  
WO/2012/153950
The present invention relates to a method for preparing t-butyl 2-((4R,6S)-6-formyl-2,2-dimethyl-1,3-dioxan-4-yl)acetate having optical activity, which is a core intermediate in the preparation of a variety of HMG-CoA reductase inhibitor...  
WO/2012/153950
The present invention relates to a method for preparing t-butyl 2-((4R,6S)-6-formyl-2,2-dimethyl-1,3-dioxan-4-yl)acetate having optical activity, which is a core intermediate in the preparation of a variety of HMG-CoA reductase inhibitor...  
WO/2012/138254
The invention relates to medicine and pharmacology. The novel 4,4'-biphenylamide derivatives are pharmacologically active and can be used as new effective allosteric modulators of АМРА receptors for treating Alzheimer's, Parkinson's ...  
WO/2012/136568
The invention relates to a method for the removal of the cyclic diester of a 2-hydroxy alkanoic acid from a vapor containing said diester, wherein the vapor is contacted with an aqueous solution so that the diester dissolves in said solu...  
WO/2012/138494
A process for making a 2-nitro-1-ethanol derivative of formula III: wherein R3 is as described herein is provided. Novel 2-nitro-1-ethanol derivatives provided.  
WO/2012/130920
The invention discloses a method for the preparation of tert-butyl 6-chloro-3,5- dioxohexanoatefrom Meldrum's acid derivative and its use for the preparation of tert-butyl (4R,6S)-(6-hydroxymethyl-2,2-dimethyl-1,3-dioxan-4-yl)acetat e(BH...  
WO/2012/133861
An amide compound represented by the formula (I): [wherein, R1, R2, R3, R4, R5, R6, R7, R8, X, W, r, n and Y are as defined in the description] has an excellent control effect on harmful arthropods.  
WO/2012/130919
The invention discloses a method for the preparation of tert-butyl 6-chloro-3,5- dioxohexanoate from Meldrum's acid derivative and its use for the preparation of tert-butyl (4R,6S)-(6-hydroxymethyl-2,2-dimethyl-1,3-dioxan-4-yl)acetat e(B...  
WO/2012/129452
This invention discloses a series of novel propynoic acid carbamoyl methyl-amides (PACMAs), methods for synthesizing the PACMAs and pharmaceutical compositions containing the PACMAs. These novel compounds and compositions show cytotoxici...  
WO/2012/129452
This invention discloses a series of novel propynoic acid carbamoyl methyl-amides (PACMAs), methods for synthesizing the PACMAs and pharmaceutical compositions containing the PACMAs. These novel compounds and compositions show cytotoxici...  
WO/2012/129452
This invention discloses a series of novel propynoic acid carbamoyl methyl-amides (PACMAs), methods for synthesizing the PACMAs and pharmaceutical compositions containing the PACMAs. These novel compounds and compositions show cytotoxici...  
WO/2012/125598
The present invention relates to compounds of formula (I): wherein R1 to R3, A, X and n are as defined herein. The compounds of formula (I) are useful as inhibitors of leukotriene A4 hydrolase (LTA4H) and treating LTA4H related disorder....  
WO/2012/118196
Provided is a method for concentrating an aqueous solution that contains at least 3-hydroxy-2,2-dimethylpropanal and/or a dimer thereof. The concentration method comprises a step wherein at least one substance selected from the group con...  
WO/2012/114347
Disclosed herein is a compound of formula (A), its salts, enantiomers, and diastereomers thereof; wherein, Rl and R2 can be (C1-C6) alkyl groups, a phenyl group, a (C5-C7) cycloalkyl groups; X and Y individually selected from H, -N02, -N...  
WO/2012/116250
The invention generally relates to functional polymers and hydrogels. More particularly, the invention provides versatile monomers and polymers with well-defined functionalities, e.g., polycarbonates and poly(ester-carbonates), compositi...  
WO/2012/110117
Disclosed is a method to prepare a polylactic acid comprising the steps of performing a ring opening polymerization using a catalyst and either a catalyst killer compound or an endcapping additive to obtain a raw polylactic acid of MW gr...  
WO/2012/110118
Disclosed is a method to prepare a polylactic acid comprising the steps of: performing a ring opening polymerization using a catalyst and either a catalyst killer compound or an endcapping additive to obtain a raw polylactic acid of MW g...  
WO/2012/107158
The invention relates to specific [1,3]-dioxan-5-one compounds, to a process for preparation thereof and to the use thereof as dyes or as fluorescent emitters for organic electroluminescent devices (OLEDs) or for organic light-emitting e...  
WO/2012/104659
A compound of Formula (I), and its pharmaceutically acceptable salt or salts and physiologically hydrolysable derivatives in free form or salt form: wherein R1 is independently selected from F, CI, Br, CN, NH2, OH, CHO, COOH, oxo, C1-4al...  
WO/2012/103279
The invention features methods and compositions for the synthesis of multimerizing agents. An exemplary method for producing AP20187 may comprise: (a) coupling 2-N,Ndimethylaminomethyl-1,3-diaminopropane with AP20792 to produce the dimer...  
WO/2012/100809
The present invention relates to liquid-crystalline compounds having an O-heterocyclic ring, three partly fluorinated benzene rings and a -CF2O- bridge between the rings. The invention also relates to liquid-crystalline media produced th...  
WO/2012/096934
Methods for preventing or treating retroviral infection, such as human immunodeficiency virus, in vivo utilize transcriptional inhibitory compounds. These include cortistatin A and analogs of the cortistatin family.  
WO/2012/065116
Disclosed herein is a polyhydroxy ketal adduct obtained by forming an ester between of a hydrocarbon polyol and at least 1.5 equivalents of a ketocarboxy to produce an intermediate ketocarboxylic ester. The intermediate polyketocarboxyli...  
WO/2012/065116
Disclosed herein is a polyhydroxy ketal adduct obtained by forming an ester between of a hydrocarbon polyol and at least 1.5 equivalents of a ketocarboxy to produce an intermediate ketocarboxylic ester. The intermediate polyketocarboxyli...  
WO/2012/059436
The invention relates to novel compounds of formula (I), in which R1, R2, R3, R4, R5, Y, Q and G are defined as indicated above, to several methods and intermediate products for the production thereof and use thereof as herbicides and/or...  
WO/2012/045734
The present invention relates to phenyl diamides according to the general formula (1) and their use as a medicament and a pharmaceutical preparation comprising as an active ingredient a phenyl diamide according to the general formula (1)...  
WO/2012/036693
The present invention involves a new synthesis route for the formation of lactylates. The method comprises reacting a dilactide with a compound comprising a hydroxy group. This reaction is preferably carried out in the presence of a cati...  
WO/2012/034958
The invention relates to compounds of general formula (3) wherein R4 is allyl, 2-butyl, cyclohexyl, 3-methyl-2-butyl or 4-methyl-2-pentyl, a method for the preparation of compounds of general formula (3) and their use in the preparation ...  
WO/2012/035123
Arylsulphonamide derivatives of formula (I) and pharmaceutically acceptable salts thereof. The compounds may be useful for the treatment and/or prevention of disorders of the central nervous system.  
WO/2012/036693
The present invention involves a new synthesis route for the formation of lactylates. The method comprises reacting a dilactide with a compound comprising a hydroxy group. This reaction is preferably carried out in the presence of a cati...  
WO/2012/032035
The invention relates to salts of acids with 2-propyl esters of general formula (2) The invention also relates to a method for the preparation of salts of acids with compounds of general formula (2) and to the use thereof in the preparat...  
WO/2012/031933
A method is described in which hydroxyacetals or hydroxyacetal mixtures are used for catalytic C-O-C linking reactions to form ethers, especially by telomerizing diene systems, wherein palladium-(0) complexes are used as catalysts, carbo...  
WO/2012/031933
A method is described in which hydroxyacetals or hydroxyacetal mixtures are used for catalytic C-O-C linking reactions to form ethers, especially by telomerizing diene systems, wherein palladium-(0) complexes are used as catalysts, carbo...  
WO/2012/029942
Provided is a compound represented by formula (1) or a pharmacologically acceptable salt thereof. (In the formula, A represents a C6-10 arylene group or the like; R1a, R1b and R1c each independently represents a hydrogen atom, a halogen ...  
WO/2012/023584
Provided are a composition derived from ascorbic acid, a method for preparing the composition, and a cosmetic material having the composition mixed therein. The composition derived from ascorbic acid comprises a reaction product obtained...  
WO/2012/017242
A process is provided for preparing a compound of the following general formula (I) wherein R1 represents hydrogen, an alkyl group of 1 to 12 carbon atoms, an aryl group of 6 to 12 carbon atoms or an aralkyl group of 7 to 12 carbon atoms...  
WO/2012/017166
or an addition salt thereof with pharmaceutically acceptable acids, for use thereof in a method for treatment of a pathological condition linked to an excessive effect of TNF-alpha and for use thereof in a method for treatment of the hum...  
WO/2012/017166
or an addition salt thereof with pharmaceutically acceptable acids, for use thereof in a method for treatment of a pathological condition linked to an excessive effect of TNF-alpha and for use thereof in a method for treatment of the hum...  
WO/2012/010172
The present invention relates to methods of producing ingenol-3-angelate (I) from ingenol (II). Formula (I) and (II). Furthermore, the invention relates to intermediates useful for the synthesis of ingenol-3-angelate (I) from ingenol (II...  
WO/2012/007379
Process for the manufacture of a cyclic diester of an alpha-hydroxyacid comprising heating the alpha-hydroxyacid at a temperature from 100 to 250°C in the presence of at least one polyol and of at least one catalyst selected from the gr...  
WO/2012/001601
The invention relates to compounds, in particular phosphinic ligands of metal complexes, as well as to metal complexes including said ligands and to supported catalysts including said metal complexes or said compounds. The invention also...  
WO/2012/000921
Process for the manufacture of lactide comprising heating lactic acid in the presence of at least one hygroscopic salt present in an amount of at least 1 mol per mol of lactic acid.  
WO/2011/163671
Compounds derived from acetone are provided. Particularly, the compounds are derivatives of hydroxyacetone, including dimers of both 1-hydroxyacetone and 1,3-dihydroxyacetone. The hydroxy moieties on the core hydroxyacetone molecule serv...  
WO/2011/163671
Compounds derived from acetone are provided. Particularly, the compounds are derivatives of hydroxyacetone, including dimers of both 1-hydroxyacetone and 1,3-dihydroxyacetone. The hydroxy moieties on the core hydroxyacetone molecule serv...  
WO/2011/159297
GPR120 agonists are provided. These compounds are useful for the treatment of metabolic diseases, including Type II diabetes and diseases associated with poor glycemic control.  
WO/2011/159219
Disclosed is a process for production of a cycloaliphatic carbonate from a diol, triol or polyol and a carbon dioxide source, such as a dialkyl carbonate. Said process is performed in a solvent-free medium using a N-heterocyclic carbene ...  

Matches 51 - 100 out of 3,567